开发和内部验证基于外周血液炎症标志物进行的诺姆图,用于预测鼻癌的预后

Jing Lai1, Peixin Lin1, Jiafeng Zhuang1

  • 1Department of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.

Cancer medicine
|March 29, 2024
PubMed
概括

新的炎症标记物,即中性粒细胞计数,血小板计数和单细胞计数乘以淋巴细胞计数 (PIV) 和血小板与白细胞比率 (PWR) 的产物,预测了鼻癌 (NPC) 患者的整体存活率. 高PIV和低PWR表明结果更差.